Worldwide data hunt for rare spinal fistula
NCT ID NCT07574645
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
SPIDER is a worldwide registry collecting data from 1,000 patients with a rare spinal blood vessel condition called spinal dural arteriovenous fistula. By pooling information from many hospitals, researchers hope to learn which treatments—surgery or endovascular procedures—work best and how patients fare over time. This study does not test a new drug or device, but aims to gather real-world evidence to guide future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could provide clearer evidence on which treatments work best for this rare spinal condition.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results depend on the quality and completeness of data from many centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL DURAL ARTERIOVENOUS FISTULA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Thomas Jefferson University Hospital
RECRUITINGPhiladelphia, Pennsylvania, 19102, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••